Detalhe da pesquisa
1.
The underlying molecular mechanisms and biomarkers between periodontitis and COVID-19.
BMC Oral Health
; 23(1): 524, 2023 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37495990
2.
Enhanced antitumour efficiency of R8GD-modified epirubicin plus tetrandrine liposomes in treatment of gastric cancer via inhibiting tumour metastasis.
J Liposome Res
; 31(2): 145-157, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32223361
3.
Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition.
J Liposome Res
; 31(2): 113-129, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32200703
4.
Functional vinorelbine plus schisandrin B liposomes destroying tumor metastasis in treatment of gastric cancer.
Drug Dev Ind Pharm
; 47(1): 100-112, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33295825
5.
RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply.
Cancer Sci
; 111(2): 621-636, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31777993
6.
Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis.
Drug Dev Ind Pharm
; 46(4): 621-634, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162988
7.
GGP modified daunorubicin plus dioscin liposomes inhibit breast cancer by suppressing epithelial-mesenchymal transition.
Drug Dev Ind Pharm
; 46(6): 916-930, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32362146
8.
Recent advances in glass-ceramics: Performance and toughening mechanisms in restorative dentistry.
J Biomed Mater Res B Appl Biomater
; 112(1): e35334, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776023
9.
Dual variable of drug loaded micelles in both particle and electrical charge on gastric cancer treatment.
J Drug Target
; 28(10): 1071-1084, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32484364
10.
Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer.
J Drug Target
; 28(3): 245-258, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462111
11.
Development of R8 modified epirubicin-dihydroartemisinin liposomes for treatment of non-small-cell lung cancer.
Artif Cells Nanomed Biotechnol
; 47(1): 1947-1960, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31079495